linkedin
At inomed, we’ve witnessed great changes in endocrine surgery. Since our founding in 1991, we’ve remained dedicated to progress, with our finger on the pulse of medical advancement. As a platinum sponsor of Eurocrine, we aim to support ongoing research and respond to the latest industry developments.
With its wealth of surgical data from across Europe, the Eurocrine registry allows users to identify trends and share best practice with the aim to decrease morbidity and mortality in endocrine tumours.
In recent years, we’ve seen a demand for less disruptive treatments. inomed now offers radiofrequency ablation (https://www.inomed.com/procedure-thyroid-nodules/) and autofluorescence (https://www.inomed.com/procedure-autofluorescence-of-the-parathyroid-glands/) to identify and preserve the crucial parathyroid glands.
👉 Visit Eurocrine’s ongoing research page to discover the projects that are at the forefront of endocrine surgery! https://eurocrine.eu/research/ongoing-research
#endocrinesurgery#medicalresearch#tumours#cancerresearch#thyroidsurgery#C2Xplore#inomed
